City

Minneapolis (1)

Tianjin (1)

Overall Status

Not yet recruiting (1)

Recruiting (1)

Terminated (1)

Phase

n/a (2)

phase 1/phase 2 (1)

Sponsor

Air Force Military Medical University, China (1)

Masonic Cancer Center, University of Minnesota (1)

Therapeutic Advances in Childhood Leukemia Consortium (1)

Collaborator

Children's Hospital of Hebei Province (1)

Qilu Hospital of Shandong University (1)

Taian City Central Hospital (1)

The Affiliated Hospital of Qingdao University (1)

The Second Hospital of Hebei Medical University (1)

Study Documents

Intervention Type

drug (3)

biological (1)

radiation (1)

Funder Type

Other (3)

Study Type

Interventional (3)

jmml

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Leukemia, Juvenile Myelomonocytic, JMML, JCML Trial (Trametinib, Azacitidine, Fludarabine)

Not yet recruiting

Leukemia, Juvenile Myelomonocytic
+4 more

Trametinib
+3 more

(no location specified)

May 4, 2023

Leukemia, Myeloid, Chronic, AML, Leukemia, Lymphocytic, Acute Trial in Minneapolis (biological, drug, radiation)

Terminated

Has Results

Leukemia, Myeloid, Chronic
+8 more

Stem Cell Transplant
+5 more

Minneapolis, Minnesota

Masonic Cancer Center, University of Minnesota

Dec 31, 2020

JMML Trial in Tianjin (Azacitidine and homoharringtonine)

Recruiting

JMML

Azacitidine and homoharringtonine

Tianjin, Tianjin, China

Institute of Hematology & Blood Diseases Hospital, Chinese Acade

Aug 6, 2020